Daptomycin Injection, Powder, Lyophilized, For Solution
NDC Package 70511-182-84

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Daptomycin injection is a medication an antibiotic used to treat serious bacterial infections. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Maia Pharmaceuticals, Inc., this product is identified by NDC 70511-182 and is authorized under FDA application NDA217630.

Identification & Billing

NDC Package Code
70511-182-84
Package Description
10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (70511-182-15)
Product Code
11-Digit Billing Format
70511018284
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Daptomycin
Non-Proprietary Name
Daptomycin
Substance Name
Daptomycin
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Usage Information
This medication is an antibiotic used to treat serious bacterial infections. It works by stopping the growth of bacteria. This medication is not recommended for use in children younger than 12 months due to possible risk of serious side effects.

Regulatory & Marketing

Labeler Name
Maia Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA217630
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-08-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70511-182-84 identifies a specific commercial package of 10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose (70511-182-15) of Daptomycin, a human prescription drug labeled by Maia Pharmaceuticals, Inc.. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains daptomycin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Maia Pharmaceuticals, Inc. on September 08, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is an antibiotic used to treat serious bacterial infections. It works by stopping the growth of bacteria. This medication is not recommended for use in children younger than 12 months due to possible risk of serious side effects.

How is this Maia Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70511018284. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70511-182-84
11-Digit CMS (5-4-2)
70511-0182-84

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.